Why We Try Stem Cells Before Surgery for Joint and Spine Pain

A Non-Surgical Path When One Joint Breaks Down the Next

Stem cell treatment in Thailand has become one of the most common reasons patients come to see us for orthopedic problems, and a recent case at our clinic shows exactly why. A patient arrived with years of chronic ankle inflammation that traced back to a joint injury earlier in life. Over time, that one damaged joint had quietly changed everything above it. To protect the weak ankle, the body shifted load elsewhere, and eventually the lower spine paid the price with multiple bulging and herniated discs. The surgery on offer was risky, expensive, and carried a real chance of failure.

This is one of the most classic patterns we see in orthopedic medicine: when one joint is compromised, the joints around it carry more weight to compensate, and year after year that compensation creates new damage. It is one problem quietly producing the next.

Why Surgery Is Rarely Our First Choice

For most orthopedic problems, surgery is not the first thing we want to recommend, and it helps to understand why. Take a herniated disc. The disc is the soft cushion that absorbs shock in the spine and protects the bone and nerves. When part of it protrudes out of its normal space, it causes pain. But look closely at what surgery actually does about it: a surgeon may trim away a piece of that cushion so it fits the space again (discectomy), remove bone to make the space larger (laminectomy), or take the cushion out entirely and replace it with a spacer or bone graft, then fuse the vertebrae together (spinal fusion).

Each of these is more about managing the symptom than fixing the root cause. And once the natural shock absorber is gone and the spine is fused, movement at that level becomes abnormal — which is exactly why the segment has to be fused in the first place.

The long-term concern here is real and well documented. It is called Adjacent Segment Disease: the healthy segments next to a fusion are forced to work harder to make up for the rigid section, and they begin to wear out themselves. Research bears this out. A systematic review and meta-analysis found that roughly 36% of patients develop degeneration in the adjacent segment and about 11% develop symptomatic adjacent segment disease within two to seven years of lumbar fusion, with advanced age among the recognized risk factors (Lumbar adjacent segment degeneration after spinal fusion: a systematic review and meta-analysis, Spine Journal, 2023). In other words, fixing one segment can set up the next one to fail. Nature rarely gives us a body part without a reason, and altering that design tends to carry a long-term cost.

What also concerns us is that, from our own observation and from the published trend data, spinal surgery is being performed on younger and younger patients. Epidemiological studies report a rising incidence of lumbar disc herniation in adolescents and young adults, driven largely by prolonged sitting, inactivity, and poor posture (Risk factors for lumbar disc herniation in adolescents and young adults, Frontiers in Surgery, 2022). That makes a conservative, root-cause-first approach more important than ever.

What Stem Cells Actually Do

This is the reason we so often wish we had met a patient earlier — before the compensation cascade and before surgery is on the table. If we can calm the inflammation and restore function in the original joint that started the problem, we give the body a chance to stop compensating.

Stem cells are a powerful tool for this, and reducing inflammation is only part of what they do. Mesenchymal stem cells work largely through what scientists call a paracrine effect: they secrete bioactive molecules — cytokines, growth factors, and signaling vesicles — that instruct the patient's own existing joint cells to begin repairing themselves. They also help shift the local immune environment from a pro-inflammatory state toward a healing one, partly by encouraging inflammatory M1 macrophages to switch to anti-inflammatory M2 macrophages (Immunoregulatory paracrine effect of mesenchymal stem cells in osteoarthritis, Frontiers in Cell and Developmental Biology, 2024). On top of this, they provide chondroprotection — helping to slow the breakdown of cartilage (Mesenchymal Stem Cell Therapy for Osteoarthritis: The Critical Role of the Cell Secretome, Frontiers in Bioengineering and Biotechnology, 2019).

Faced with all of this, our patient made the decision to try stem cells before committing to surgery — and you can learn more about our stem cell therapy options here.

Why We Chose an IV Drip for This Case

Because the problem sat in more than one location — the ankle and several levels of the spine — injecting each site one by one was not the most sensible approach. Instead we used a stem cell IV infusion. Infused stem cells have a natural property called homing: once in the bloodstream they migrate toward sites of injury and inflammation, guided by chemical distress signals from the damaged tissue (Mesenchymal Stem Cells Home to Sites of Injury and Inflammation, Journal of Inflammation Research). It is worth being precise here: after IV delivery the cells are first transiently caught in the lungs before redistributing to where they are needed, so this is a whole-body, signal-driven approach rather than a guaranteed single-target one.

Every patient's response is individual, and stem cell therapy is not a guaranteed cure. But in this case the early response was encouraging — within the first few days the patient described a substantial easing of pain and swelling in the ankle. With disc and cartilage repair, the more meaningful work happens over the following weeks and months, so we expect the fuller picture to emerge over a longer horizon.

When chronic pain has been narrowing someone's life and they tell us it is easing, the whole team feels it with them. Helping a patient move out of constant pain and back into a fuller life is, honestly, the best part of this work.

Frequently Asked Questions

Is stem cell treatment a real alternative to spinal surgery? For some patients, yes — particularly when the goal is to reduce inflammation and support the body's own repair rather than mechanically remove or fuse tissue. It is not right for every case, and severe structural problems or nerve compression may still require surgical input. The point is to explore conservative options first, before irreversible surgery, when it is clinically reasonable to do so.

How soon do people feel results from stem cell therapy? It varies a great deal between individuals. Some notice changes in inflammation and pain within days, while cartilage and disc-related repair is a slower process that unfolds over weeks to months. Early improvement is encouraging but not a substitute for assessing the result over a longer period.

Why use an IV drip instead of injecting the joint directly? When problems exist in several locations at once, an IV infusion lets the cells travel through the circulation and home toward multiple sites of inflammation, rather than targeting just one joint. For a single isolated joint, a direct injection may still be the better choice — the right method depends on the case.

A note on this story: every post in this series comes from a real Google review written by one of our patients in their own words. We retell it here from the doctor's perspective, with names, ages, and identifying details removed to protect each patient's privacy. No one is paid or pressured to leave a review — these patients chose to share their experience in the hope it helps someone facing the same problem. You can read our patients' own reviews on Google.

References

1. Lumbar adjacent segment degeneration after spinal fusion surgery: a systematic review and meta-analysis. The Spine Journal (2023). https://pubmed.ncbi.nlm.nih.gov/36345970/

2. Risk factors for lumbar disc herniation in adolescents and young adults: a case–control study. Frontiers in Surgery (2022). https://www.frontiersin.org/journals/surgery/articles/10.3389/fsurg.2022.1009568/full

3. Immunoregulatory paracrine effect of mesenchymal stem cells and mechanism in the treatment of osteoarthritis. Frontiers in Cell and Developmental Biology (2024). https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2024.1411507/full

4. Mesenchymal Stem Cell Therapy for Osteoarthritis: The Critical Role of the Cell Secretome. Frontiers in Bioengineering and Biotechnology (2019). https://pmc.ncbi.nlm.nih.gov/articles/PMC6361779/

5. Mesenchymal Stem Cells Home to Sites of Injury and Inflammation. Journal of Inflammation Research / PMC. https://pmc.ncbi.nlm.nih.gov/articles/PMC3623614/

6. Lumbar Discectomy (patient education). Mayfield Brain & Spine. https://mayfieldclinic.com/pe-lumdiscectomy.htm

7. Spinal Surgery: Laminectomy and Fusion. Aetna Clinical Policy Bulletin. https://www.aetna.com/cpb/medical/data/700_799/0743.html

8. Lumbar Discectomy vs. Fusion: Understanding the Surgical Options. Southeastern Orthopedics. https://se-ortho.com/lumbar-discectomy-vs-fusion-which-surgery-is-right-for-me/